EQUITY RESEARCH MEMO

InterChem

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)60/100

InterChem is a US-based pharmaceutical services company specializing in the sourcing, logistics, and transportation of Active Pharmaceutical Ingredients (APIs) and antibiotics. Founded in 2005 and headquartered in San Diego, the company acts as a trusted intermediary, managing supply chain risk and coordinating custom manufacturing for pharmaceutical clients. Leveraging decades of industry relationships, InterChem ensures FDA-compliant and reliable sourcing, positioning itself as a critical partner in the pharmaceutical supply chain. Despite being private and lacking disclosed funding or valuation, the company's consistent focus on API logistics and its established network suggest a stable, though not high-growth, business model. The company's profile remains low in public visibility, with no recent news or regulatory milestones identified.

Upcoming Catalysts (preview)

  • Q4 2026Expansion of API sourcing capabilities through new supplier agreements65% success
  • TBDPotential contract win with a major pharmaceutical company for custom manufacturing coordination50% success
  • Q2 2027Adoption of digital supply chain tracking technology to enhance transparency40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)